Anika Therapeutics - 27 Year Stock Price History | ANIK

Historical daily share price chart and data for Anika Therapeutics since 1993 adjusted for splits. The latest closing stock price for Anika Therapeutics as of July 08, 2020 is 35.30.
  • The all-time high Anika Therapeutics stock closing price was 73.36 on October 25, 2019.
  • The Anika Therapeutics 52-week high stock price is 75.72, which is 114.5% above the current share price.
  • The Anika Therapeutics 52-week low stock price is 22.01, which is 37.6% below the current share price.
  • The average Anika Therapeutics stock price for the last 52 weeks is 45.79.
Anika Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 36.6923 52.4000 54.0600 22.3800 35.3000 -31.92%
2019 45.1985 34.5200 73.3600 29.3700 51.8500 54.27%
2018 43.2097 54.9100 68.4300 28.7700 33.6100 -37.66%
2017 50.3632 50.1100 59.9400 41.7200 53.9100 10.11%
2016 45.8884 38.0800 54.2600 35.3000 48.9600 28.30%
2015 37.2732 39.7600 45.2100 31.3500 38.1600 -6.33%
2014 41.0168 34.9900 50.4300 29.4800 40.7400 6.76%
2013 20.0087 10.8700 38.1600 10.2200 38.1600 283.90%
2012 12.7090 9.3100 17.5400 9.0800 9.9400 1.43%
2011 7.5280 6.7300 11.1700 5.3300 9.8000 46.93%
2010 6.2777 7.5600 7.9000 4.9500 6.6700 -12.58%
2009 5.6700 3.1200 9.0500 3.0500 7.6300 150.99%
2008 8.3621 15.1800 15.1800 3.0000 3.0400 -79.11%
2007 15.4437 13.1700 21.8000 12.3100 14.5500 9.65%
2006 11.9701 11.5400 14.7400 9.5000 13.2700 13.52%
2005 12.1348 9.0000 17.0000 8.1000 11.6900 27.76%
2004 11.4183 9.3600 17.5300 6.8000 9.1500 -6.06%
2003 4.1682 1.0400 11.5000 0.9900 9.7400 883.84%
2002 1.1214 1.1000 1.3900 0.8500 0.9900 -1.00%
2001 1.1379 0.8125 1.6880 0.8125 1.0000 27.99%
2000 4.2242 7.0000 11.5000 0.7500 0.7813 -88.94%
1999 5.9460 5.0630 8.6880 4.5000 7.0630 31.40%
1998 10.2554 8.6250 18.1900 3.9380 5.3750 -42.28%
1997 6.7512 3.8750 10.5000 3.8750 9.3130 148.35%
1996 4.7312 3.8800 7.5000 3.4400 3.7500 -3.23%
1995 2.5569 1.8750 3.8750 1.6200 3.8750 106.67%
1994 2.7154 4.0310 4.1250 1.5000 1.8750 -58.04%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.501B $0.115B
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.997B 16.30
Bristol Myers Squibb (BMY) United States $134.766B 11.26
Gilead Sciences (GILD) United States $94.843B 12.29
CSL (CSLLY) Australia $89.938B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.725B 52.75
Regeneron Pharmaceuticals (REGN) United States $70.449B 27.16
Illumina (ILMN) United States $54.371B 55.87
Biogen (BIIB) United States $45.724B 7.83
Seattle Genetics (SGEN) United States $30.385B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.107B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.849B 10.25
Incyte (INCY) United States $23.535B 0.00
BioMarin Pharmaceutical (BMRN) United States $23.279B 211.03
Genmab (GMAB) Denmark $23.005B 18.95
Moderna (MRNA) United States $22.860B 0.00
Genmab (GNMSF) Denmark $21.647B 64.27
Alnylam Pharmaceuticals (ALNY) United States $18.506B 0.00
BeiGene (BGNE) Cayman Islands $15.873B 0.00
BioNTech SE (BNTX) Germany $15.286B 0.00
Exact Sciences (EXAS) United States $13.742B 0.00
Sarepta Therapeutics (SRPT) United States $13.270B 0.00
Galapagos (GLPG) Belgium $13.081B 38.48
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
ARGENX SE-ADR (ARGX) Netherlands $11.817B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.210B 27.59
Bio-Techne Corp (TECH) United States $10.473B 69.19
QIAGEN (QGEN) Netherlands $9.923B 28.85
Immunomedics (IMMU) United States $9.594B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.791B 0.00
Guardant Health (GH) United States $8.241B 0.00
Exelixis (EXEL) United States $7.334B 25.72
Ascendis Pharma (ASND) Denmark $6.971B 0.00
Repligen (RGEN) United States $6.553B 114.94
Adaptive Biotechnologies (ADPT) United States $6.193B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.835B 125.56
Novavax (NVAX) United States $5.697B 0.00
Acceleron Pharma (XLRN) United States $5.505B 0.00
Vir Biotechnology (VIR) United States $5.432B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.369B 0.00
Reata Pharmaceuticals (RETA) United States $5.251B 0.00
Mirati Therapeutics (MRTX) United States $5.193B 0.00
Zai Lab (ZLAB) China $5.048B 0.00
Emergent Biosolutions (EBS) United States $4.950B 32.44
MyoKardia (MYOK) United States $4.448B 0.00
MorphoSys AG (MOR) Germany $4.393B 34.07
Blueprint Medicines (BPMC) United States $4.263B 0.00
China Biologic Products (CBPO) China $4.244B 23.59
Global Blood Therapeutics (GBT) United States $4.165B 0.00
Amicus Therapeutics (FOLD) United States $4.066B 0.00
Momenta Pharmaceuticals (MNTA) United States $4.061B 0.00
Halozyme Therapeutics (HALO) United States $3.872B 0.00
NeoGenomics (NEO) United States $3.804B 277.77
Inovio Pharmaceuticals (INO) United States $3.709B 0.00
Bluebird Bio (BLUE) United States $3.692B 0.00
Arena Pharmaceuticals (ARNA) United States $3.346B 0.00
Alkermes (ALKS) Ireland $3.239B 63.77
Deciphera Pharmaceuticals (DCPH) United States $3.173B 0.00
Fate Therapeutics (FATE) United States $2.930B 0.00
Insmed (INSM) United States $2.869B 0.00
Denali Therapeutics (DNLI) United States $2.863B 0.00
Amarin (AMRN) Ireland $2.610B 0.00
PHARMA MAR SA (PHMMF) Spain $2.470B 0.00
Twist Bioscience (TWST) United States $2.237B 0.00
Viela Bio (VIE) United States $2.207B 0.00
UniQure (QURE) Netherlands $2.075B 0.00
Alector (ALEC) United States $1.920B 0.00
Editas Medicine (EDIT) United States $1.913B 0.00
Eidos Therapeutics (EIDX) United States $1.898B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.896B 0.00
Principia Biopharma (PRNB) United States $1.863B 0.00
Ligand Pharmaceuticals (LGND) United States $1.797B 69.98
Forma Therapeutics Holdings (FMTX) United States $1.741B 0.00
Adverum Biotechnologies (ADVM) United States $1.738B 0.00
Zymeworks (ZYME) Canada $1.698B 0.00
I-Mab (IMAB) China $1.673B 0.00
Intra-Cellular Therapies (ITCI) United States $1.665B 0.00
Epizyme (EPZM) United States $1.642B 0.00
Cytokineticsorporated (CYTK) United States $1.601B 0.00
Mersana Therapeutics (MRSN) United States $1.530B 0.00
Sorrento Therapeutics (SRNE) United States $1.529B 0.00
Mesoblast (MESO) Australia $1.509B 0.00
Sangamo Therapeutics (SGMO) United States $1.495B 0.00
Beam Therapeutics (BEAM) United States $1.494B 0.00
Revance Therapeutics (RVNC) United States $1.488B 0.00
NantKwest (NK) United States $1.477B 0.00
Zealand Pharma (ZEAL) Denmark $1.469B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.451B 0.00
REGENXBIO (RGNX) United States $1.449B 0.00
Akcea Therapeutics (AKCA) United States $1.404B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NGM Biopharmaceuticals (NGM) United States $1.353B 0.00
Arvinas (ARVN) United States $1.328B 0.00
Intellia Therapeutics (NTLA) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.276B 8.91
Adaptimmune Therapeutics (ADAP) United Kingdom $1.223B 0.00
Arcus Biosciences (RCUS) United States $1.164B 0.00
Athenex (ATNX) United States $1.091B 0.00
Compugen (CGEN) Israel $1.090B 0.00
Alcobra (ARCT) United States $1.018B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.986B 0.00
VBI Vaccines (VBIV) United States $0.911B 0.00
Retrophin (RTRX) United States $0.899B 0.00
Dynavax Technologies (DVAX) United States $0.868B 0.00
Myriad Genetics (MYGN) United States $0.868B 44.77
Heska (HSKA) United States $0.847B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.830B 0.00
Pharming Group (PHGUF) Netherlands $0.820B 21.83
Intrexon (PGEN) United States $0.775B 0.00
Morphic Holding (MORF) United States $0.766B 0.00
Kadmon Holdings (KDMN) United States $0.752B 0.00
Cellectis S.A (CLLS) France $0.750B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.735B 0.00
Castle Biosciences (CSTL) United States $0.723B 0.00
Frequency Therapeutics (FREQ) United States $0.712B 0.00
Codexis (CDXS) United States $0.708B 0.00
Vericel (VCEL) United States $0.686B 126.75
ZIOPHARM Oncology Inc (ZIOP) United States $0.685B 0.00
Cue Biopharma (CUE) United States $0.670B 0.00
Agenus (AGEN) United States $0.658B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.632B 5.41
AnaptysBio (ANAB) United States $0.621B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
MiMedx (MDXG) United States $0.591B 0.00
Kala Pharmaceuticals (KALA) United States $0.581B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.566B 0.00
Athersys (ATHX) United States $0.550B 0.00
Syros Pharmaceuticals (SYRS) United States $0.548B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.535B 0.00
Cel-Sci (CVM) United States $0.527B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
UROGEN PHARMA (URGN) United States $0.513B 0.00
NextCure (NXTC) United States $0.512B 0.00
Protagonist Therapeutics (PTGX) United States $0.511B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.506B 0.00
Scholar Rock Holding (SRRK) United States $0.502B 0.00
DBV Technologies S.A (DBVT) France $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.491B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.467B 0.00
MeiraGTx Holdings (MGTX) United States $0.466B 0.00
Geron (GERN) United States $0.443B 0.00
Merus (MRUS) Netherlands $0.443B 0.00
Prothena (PRTA) Ireland $0.436B 0.00
Precision BioSciences (DTIL) United States $0.430B 0.00
Seres Therapeutics (MCRB) United States $0.428B 0.00
BioDelivery Sciences (BDSI) United States $0.428B 22.47
Aeglea BioTherapeutics (AGLE) United States $0.410B 0.00
Puma Biotechnology (PBYI) United States $0.403B 0.00
MannKind (MNKD) United States $0.388B 0.00
CytomX Therapeutics (CTMX) United States $0.385B 0.00
Albireo Pharma (ALBO) United States $0.382B 0.00
Kamada (KMDA) Israel $0.371B 15.44
Avid Bioservices (CDMO) United States $0.369B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
ANI Pharmaceuticals (ANIP) United States $0.352B 6.97
Affimed (AFMD) Germany $0.349B 0.00
OSMOTICA PHARM (OSMT) United States $0.328B 0.00
Prometic Life Sciences (LMNL) Canada $0.328B 0.00
PDL BioPharma (PDLI) United States $0.324B 284.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Cellular Biomedicine (CBMG) United States $0.303B 0.00
ChromaDex (CDXC) United States $0.293B 0.00
Spero Therapeutics (SPRO) United States $0.291B 0.00
Abeona Therapeutics (ABEO) United States $0.286B 0.00
Menlo Therapeutics (MNLO) United States $0.285B 0.00
Pfenex (PFNX) United States $0.282B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.275B 0.00
Celldex Therapeutics (CLDX) United States $0.274B 0.00
IBio (IBIO) United States $0.273B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.256B 0.00
IVERIC Bio (ISEE) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
Verastem (VSTM) United States $0.249B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.247B 0.00
Dyadic (DYAI) United States $0.246B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.238B 0.00
Selecta Biosciences (SELB) United States $0.238B 0.00
Five Prime Therapeutics (FPRX) United States $0.236B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.234B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Aduro Biotech (ADRO) United States $0.218B 0.00
Aptinyx (APTX) United States $0.218B 0.00
XOMA (XOMA) United States $0.214B 0.00
Liquidia Technologies (LQDA) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Strongbridge Biopharma (SBBP) United States $0.208B 0.00
Exicure (XCUR) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.206B 3.11
Sutro Biopharma (STRO) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.185B 0.00
Bellus Health (BLU) Canada $0.179B 0.00
Trevena (TRVN) United States $0.173B 0.00
Theratechnologies (THTX) Canada $0.170B 0.00
Kindred Biosciences (KIN) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
Aytu Bioscience (AYTU) United States $0.159B 0.00
Cyclerion Therapeutics (CYCN) United States $0.158B 0.00
VTv Therapeutics (VTVT) United States $0.156B 0.00
Cerecor (CERC) United States $0.155B 0.00
Applied Genetic Technologies (AGTC) United States $0.154B 0.00
Cidara Therapeutics (CDTX) United States $0.153B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Lumos Pharma (LUMO) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.136B 0.00
Biofrontera AG (BFRA) Germany $0.135B 0.00
PHASEBIO PHARMA (PHAS) United States $0.134B 0.00
Orgenesis (ORGS) United States $0.131B 0.00
Oncobiologics (OTLK) United States $0.131B 0.00
Arbutus Biopharma (ABUS) United States $0.130B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.119B 3.06
Lineage Cell Therapeutics (LCTX) United States $0.118B 0.00
Celsion (CLSN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
AIT Therapeutics (XAIR) United States $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.109B 0.00
Eton Pharmaceuticals (ETON) United States $0.109B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Cardiff Oncology (CRDF) United States $0.095B 0.00
Windtree Therapeutics (WINT) United States $0.095B 0.00
Cocrystal Pharma (COCP) United States $0.094B 0.00
Unum Therapeutics (UMRX) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.088B 0.00
Emmaus Life Sciences (EMMA) United States $0.086B 0.00
Organovo Holdings (ONVO) United States $0.084B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
AnPac Bio-Medical Science (ANPC) China $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
Stealth BioTherapeutics (MITO) United States $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Soligenix (SNGX) United States $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Signal Genetics (MGEN) United States $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Ecology Coatings (ABVC) United States $0.051B 0.00
Pulmatrix (PULM) United States $0.049B 0.00
Curis (CRIS) United States $0.047B 0.00
Edesa Biotech (EDSA) Canada $0.045B 0.00
Apricus Biosciences (SEEL) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Bionano Genomics (BNGO) United States $0.040B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
OvaScience (MLND) United States $0.032B 0.00
Spherix (AIKI) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
BioCardia (BCDA) United States $0.016B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
VIVUS (VVUS) United States $0.012B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00